A&O Shearman advises on Kestra Medical Technologies initial public offering

Kestra is a commercial-stage medical device company that has developed a next generation wearable cardioverter defibrillator used to protect patients at an elevated risk of sudden cardiac arrest. The device automatically monitors elevated risk patients and, if needed, delivers a defibrillation shock to return the patient’s heart to normal rhythm.